Carfilzomib Interactions
There are 356 drugs known to interact with carfilzomib, along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 115 are major, and 241 are moderate.
- View all 356 medications that may interact with carfilzomib
- View carfilzomib alcohol/food interactions (1)
- View carfilzomib disease interactions (12)
Most frequently checked interactions
View interaction reports for carfilzomib and the medicines listed below.
- Ambien (zolpidem)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Calcium 600 D (calcium / vitamin d)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Colace (docusate)
- Compazine (prochlorperazine)
- Copper (copper gluconate)
- Decadron (dexamethasone)
- Dexamethasone Intensol (dexamethasone)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glycerol (glycerin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Pomalyst (pomalidomide)
- Prilosec (omeprazole)
- Quercetin (bioflavonoids)
- Revlimid (lenalidomide)
- Tylenol (acetaminophen)
- Velcade (bortezomib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
- Zyrtec (cetirizine)
Carfilzomib alcohol/food interactions
There is 1 alcohol/food interaction with carfilzomib.
Carfilzomib disease interactions
There are 12 disease interactions with carfilzomib which include:
- TLS
- cardiac disease
- dyspnea
- hemorrhage
- hepatic toxicity
- hypertension
- PRES
- pulmonary hypertension
- pulmonary toxicity
- renal failure
- TTP/HUS
- venous thrombosis
Report options
More about carfilzomib
- carfilzomib consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: proteasome inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
